December 10, 2010 / 11:57 AM / 9 years ago

Sanofi names Charmeil new vaccines chief

* Olivier Charmeil to replace Wayne Pisano on Jan. 1

* Charmeil has emerging markets expertise -CEO

PARIS, Dec 10 (Reuters) - Sanofi-Aventis (SASY.PA), the French drugmaker mounting an $18.5 billion pursuit for control of Genzyme, named a new emerging markets-focused chief for its vaccines division on Friday. Olivier Charmeil, currently responsible for pharmaceutical operations in Asia-Pacific and Japan, will replace Wayne Pisano as senior vice-president of vaccines on Jan. 1, Sanofi said in a statement.

Sanofi Chief Executive Christopher Viehbacher cited Charmeil’s expertise in emerging markets as one of the “core” strengths needed to boost the vaccines unit. (Reporting by Lionel Laurent; Editing by Hans Peters)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below